# Ganirelix Acetate

NDC: 78206-138
Generic name: Ganirelix Acetate
Labeler / Manufacturer: Organon LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20210601

FDA application: NDA021057

## Active ingredients

- GANIRELIX ACETATE: 250 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"78206-138"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=78206-138
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fb74ff-993a-49fe-8943-e029372b863e